Press Release
Bolt Biotherapeutics Announces Initiation of BDC-1001 Clinical Trial in Patients with HER2-Expressed Solid Tumors
Press Release
Bolt Biotherapeutics Appoints Dr. Nils Lonberg to its Scientific Advisory Board
Press Release
Bolt Biotherapeutics Expands Scientific Advisory Board with Appointment of Dr. Priti Hegde
Press Release
Bolt Biotherapeutics Presents Data At SITC Conference Showing Eradication of Large Tumors in Preclinical Studies
Press Release
Bolt Strengthens Scientific Advisory Board Through Addition of Drs. Lawrence Fong, Roy Herbst and Bruce Roth
Press Release
Randall Schatzman, Ph.D., joins Bolt Biotherapeutics as CEO and a member of the board of directors, bringing over 30 years of biotech industry leadership experience
Press Release
Bolt Biotherapeutics Presents Preclinical Proof of Concept Data at American Association for Cancer Research (AACR) Conference
Press Release
Bolt Biotherapeutics Completes $54 Million Series B Financing